[Form 3] ProPhase Labs, Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

ProPhase Labs (PRPH) disclosed an initial beneficial ownership report on Form 3 for director Carolina Abenante. The filing states that she beneficially owns no securities of the company as of 06/20/2025, the date she became a director. The form was filed by one reporting person and confirms no non-derivative or derivative holdings.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Abenante Carolina

(Last) (First) (Middle)

626 RXR PLAZA, 6TH FLOOR

(Street)

UNIONDALE, NY 11556

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/20/2025

3. Issuer Name and Ticker or Trading Symbol
ProPhase Labs, Inc. [ PRPH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 is being filed to reflect the reporting person's beneficial ownership (none) as of the date of becoming an officer/director and to complete the reporting record under Section 16(a).

No securities are beneficially owned.

	/s/ Carolina Abenante	11/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ProPhase Labs (PRPH) report in this Form 3?

It reports that director Carolina Abenante has no securities beneficially owned as of 06/20/2025.

Who is the reporting person in PRPH’s Form 3?

The reporting person is Carolina Abenante, listed as a Director.

What is the event date for this ownership report?

The event date is 06/20/2025.

How many PRPH shares or derivatives does the director own?

None. The filing states no non-derivative or derivative securities are beneficially owned.

Is this Form 3 a joint or group filing?

It is filed by one reporting person.

Why was this Form 3 filed?

To reflect the reporting person's beneficial ownership status (none) as of becoming a director and to complete the record under Section 16(a).

What is Form 3?

Form 3 is an initial statement of beneficial ownership required under Section 16(a) for company insiders.